Skip to content

Study of Low Level Laser Therapy and Word Recognition in Hearing Impaired Individuals

The Effects of the Erchonia Hearing Laser on Word Recognition in Hearing Impaired Individuals Clinical Study Protocol

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00787189
Enrollment
80
Registered
2008-11-07
Start date
2007-08-31
Completion date
2008-06-30
Last updated
2021-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sensorineural Hearing Loss

Keywords

sensorineural hearing loss, tinnitus, word recognition

Brief summary

The purpose of this clinical study is to determine the effectiveness of low level laser light therapy when applied around the head and ears in improving unaided word recognition in ears with sensorineural hearing loss.

Detailed description

Sensorineural hearing loss accounts for about 90% of all hearing loss and is found in 23% of individuals older than 65 years. Sensorineural hearing loss occurs when the hair cells of the inner ear and the neural pathways to the auditory cortex are damaged. In most cases, sensorineural hearing loss cannot be improved, reversed or 'cured.' Current treatment options focus on methods that amplify external sounds and on teaching the patient various strategies to 'retrain' the brain to interpret external stimuli. Low Level Laser Therapy was first applied for the treatment of inner ear diseases by Uwe Witt, MD of Hamburg, Germany in the 1980's. Hearing impaired patients have inflammation and/or atrophy of the tissues and neural pathways connected to and supporting the cochlea's cilia hair structure, the hearing mechanism of the inner ear. Low level laser therapy is believed to stimulate the mitochondria of the adipocyte cells, which subsequently increases the production of ATP. The resultant surge in ATP production works to repair damaged tissue and regenerate cells reversing some of the damage incurred to the cochlea and thus improving aspects of hearing function.

Interventions

DEVICEThe Hearing Laser

Two 6-minute low level laser light applications to the head/neck/ears region, each one week apart.

DEVICEPlacebo Laser

inactive low level laser light therapy with no therapeutic output

Sponsors

Erchonia Corporation
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Sensorineural hearing loss. * Mild or greater degree. * Adult onset. * Gradual onset. * Hearing loss stable over past 12 months. * Etiology of presbyacusis or noise-induced hearing loss. * Unaided word recognition score between 28% and 86%. * English as primary spoken language. * Willing and able to abstain from other treatments or medications to improve hearing ability. * Willing and able to abstain from work or other activities that involve loud noise exposure.

Exclusion criteria

* Central auditory processing disorder. * Active/recurrent middle ear infection. * Meniere's disease. * Tympanic membrane perforation/tubes. * Cochlear implant. * Removal of acoustic neuroma. * Hyperacusis/misphonia. * Photosensitivity disorder. * Active infection/wound in head/ear region. * Pregnant/lactating. * Serious mental health illness. * Significant developmental disability/cognitive impairment. * History of drug/alcohol abuse. * Involvement in litigation/worker's compensation/disability benefits for hearing loss. * Other research participation in past 90 days. * Use of ototoxic medications known to cause temporary or permanent hearing loss.

Design outcomes

Primary

MeasureTime frameDescription
Participants Whose Change in Percent Correct Word Recognition Scores From Baseline to One Week After Study Treatment Equalled or Exceeded the Minimum Change in a Reference Chart.baseline and one weekParticipants were asked to repeat 50 words presented one at a time through headphones to each ear separately at a comfortable listening level to the participant. The 50 words were from a phonetically-balanced list of monosyllabic words called the Central Institute for the Deaf (CID) W-22 lists. For each ear, each word repeated correctly was scored '1'. The total number correct for each ear was summed and multiplied by 2 to attain the percent of total words repeated correctly for each ear. The change in this percent from baseline to one week after study treatment was referenced against a chart. If the change was equal to or greater than the corresponding value in the chart, the participant was considered to have a successful study outcome.

Countries

United States

Participant flow

Recruitment details

40 subjects (80 ears) were recruited across two hearing aid and evaluation test sites from May, 2007 to October, 2008.

Pre-assignment details

4 subjects (8 ears) were disqualified because the word recognition score recorded for study qualification purposes exceeded the upper inclusive limit of 86% words correct. 4 subjects (8 ears) were disqualified because the subject's primary spoken language was not English, which was also a study exclusion criteria.

Participants by arm

ArmCount
Active
Active laser device
32
Control
Placebo laser device
32
Total64

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up22

Baseline characteristics

CharacteristicActiveControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
26 Participants32 Participants58 Participants
Age, Categorical
Between 18 and 65 years
6 Participants0 Participants6 Participants
Age, Continuous78.94 years
STANDARD_DEVIATION 5.92
76.00 years
STANDARD_DEVIATION 9.86
77.47 years
STANDARD_DEVIATION 8.265
Sex: Female, Male
Female
10 Participants18 Participants28 Participants
Sex: Female, Male
Male
22 Participants14 Participants36 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 320 / 32
serious
Total, serious adverse events
0 / 320 / 32

Outcome results

Primary

Participants Whose Change in Percent Correct Word Recognition Scores From Baseline to One Week After Study Treatment Equalled or Exceeded the Minimum Change in a Reference Chart.

Participants were asked to repeat 50 words presented one at a time through headphones to each ear separately at a comfortable listening level to the participant. The 50 words were from a phonetically-balanced list of monosyllabic words called the Central Institute for the Deaf (CID) W-22 lists. For each ear, each word repeated correctly was scored '1'. The total number correct for each ear was summed and multiplied by 2 to attain the percent of total words repeated correctly for each ear. The change in this percent from baseline to one week after study treatment was referenced against a chart. If the change was equal to or greater than the corresponding value in the chart, the participant was considered to have a successful study outcome.

Time frame: baseline and one week

ArmMeasureValue (NUMBER)
ActiveParticipants Whose Change in Percent Correct Word Recognition Scores From Baseline to One Week After Study Treatment Equalled or Exceeded the Minimum Change in a Reference Chart.15 participants
ControlParticipants Whose Change in Percent Correct Word Recognition Scores From Baseline to One Week After Study Treatment Equalled or Exceeded the Minimum Change in a Reference Chart.2 participants
p-value: <0.0005Fisher Exact

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026